ACAD icon

Acadia Pharmaceuticals
ACAD

Overview Fund Activity

226 hedge funds and large institutions have $2.75B invested in Acadia Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 81 reducing their positions, and 23 closing their positions.

Holders
226
Holders Change
+4
Holders Change %
+1.8%
% of All Funds
3.65%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
29
Increased
73
Reduced
81
Closed
23
Calls
$11.3M
Puts
$4M
Net Calls
+$7.33M
Net Calls Change
+$3.5M

Top Buyers

1
AWA
1
Arete Wealth Advisors
Illinois
$275M
2
B
2
Braidwell
Connecticut
$23.8M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$17.8M
4
JAM
4
Jupiter Asset Management
United Kingdom
$17.3M
5
State Street
5
State Street
Massachusetts
$123M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$149M
2
BC
2
Boxer Capital
California
$0
3
FFM
3
Fairmount Funds Management
Pennsylvania
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$68.1M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$67.2M
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
251
Group One Trading
Illinois
– – – –
Wolverine Trading
252
Wolverine Trading
Illinois
– – – –
SFG
253
Steward Financial Group
Texas
$0 19 +19 New
7 8 9 10
11